The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure. Researchers in the Michael E. DeBakey Department of Surgery at ...
Ischemic heart disease, the leading cause of death in the United States, has long puzzled researchers. While high serum cholesterol levels are linked to cardiovascular risk, the role of dietary fat ...
Congestive heart failure is a chronic heart condition that usually occurs in older people However people with a history of ...
Ischemic heart disease affects more than 18 million Americans, making it the leading cause of death nationwide. This condition occurs when coronary arteries become narrowed or blocked, restricting ...
BioCardia ®, Inc. [NASDAQ: BCDA] , a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the FDA has accepted its ...
Echocardiography outcomes show treated patients having reduced negative remodeling of heart volumesSUNNYVALE, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of ...
Using data from the PROVE-HF study, investigators conducted a subanalysis of outcomes among patients receiving sacubitril/valsartan who did and did not have ischemic heart disease.
According to WHO, the leading cause of death among women in India in 2021 after COVID-19 was ischemic heart disease (IHD). While COVID-19 claimed 159.9 lives per 1,00,000 population, IHD caused 99.4 ...
The Daily Galaxy on MSN
Japan approves the world’s first treatments made with reprogrammed human cells
Japan has cleared two therapies that began with the same lab technique and ended in very different parts of the body. One is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results